Noninvasive glucose monitors have been anticipated by diabetes patients for over a decade. The traditional finger prick method has been a standard disease management tool for decades. But issues of patient compliance and the limitations of current methods in detecting short-term fluctuations in glucose levels have brought a host of companies into the hunt for less invasive and more user-friendly alternatives.
Now the convergence of small-scale electronics and sophisticated biocompatible product designs is giving hope for a better future to millions of diabetes patients worldwide. Noninvasive glucose monitors that can measure glucose levels accurately and reliably have the capability to improve glycemic control and patient well-being. By integrating the sensing element, electronics, and a power source in a single package, noninvasive monitors are creating new options for caregivers and their diabetes patients. Signal processing improvements - include improved signal-to-noise ratios and interference filtering - will continue to be critical to the commercialization prospects of noninvasive monitors.
What You Will Learn
- What are the noninvasive glucose sensing and monitoring technologies that are still being pursued, who are the players behind them, and what is their development status?
- What are the key noninvasive glucose monitor device design issues and evolving market factors?
- What is the global market potential for noninvasive glucose monitors today? What will it be in 2024?
- What will be the likely impact of the availability of commercial noninvasive glucose sensing technology and devices on diabetes management markets?
- Who are the market participants in the noninvasive glucose monitoring sector? What are their technology, product development activities and business strategies?
- What will be the impact of economic, technology, and regulatory factors on the commercial potential of noninvasive glucose monitors?
Who Should Read this Report
- Drug Developers
- Device Suppliers
- Clinical Trial Mgmt
- Pharma Managers
- Biotech Managers
- Drug Marketers
- Industry Strategists
- Financial Analysts
- Management Consultants
- Clinical Managers
- Drug Distributors
- Pharma Regulators
- FDA Consultants
- Managed Care Managers
1. Executive Summary
2. Glucose Sensing Market Overview
- Monitoring Glucose Levels
- Key Factors in Patient Compliance
3. Market Drivers
- Industry Alignment and Competitive Landscape
- Noninvasive Glucose Measurement Design Factors
- Measuring Glucose in Interstitial Fluid
- Patient/User Interface
- Data Collection & Reporting
- Commercial Track NGM Technologies
- Reverse Iontophoresis
- Recent Applied Research in Glucose Measurement
- Continuous Glucose Monitoring
- Near-term Noninvasive Glucose Measurement Device Analysis
- Optical Data Collection
- Direct Analyte Measurement
- Multimode Sensing
- Important Private Research Programs
- North America
5. Commercialization Factors
- Calibration Frequency
- Accuracy & Precision
- Sensor Technology & Signal Processing Advances
- Market Factors
- Asia (Japan)
- Clinical Trials
- Current/Ongoing Clinical Trials
- Concluded Clinical Trials
- Patient/Consumer Sentiment
7. Company Profiles
Research methodology is based on primary research in the form of in-depth interviews with key market participants, technology developers, distributors, industry experts, and market influencers, a list that includes regulatory officials, industry trade groups, and materials standards organizations.
Primary data is evaluated and normalized against secondary sources including trade journal articles, technical literature, industry publications, company data sheets and published information, and statistical data from government agencies and trade associations.
Forecasts and projections of market demand and future market activity are derived using standard modeling and statistical techniques.